References

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Pregnancy at age 35 years or older: ACOG Obstetric Care Consensus No. 11

10.1097/aog.0000000000004873 · 2022 · External reference

Exploring the complex landscape of delayed childbearing: factors, history, and long-term implications

10.7759/cureus.46291 · 2023 · External reference

Age at first birth, mode of conception and psychological wellbeing in pregnancy: findings from the parental age and transition to parenthood Australia (PATPA) study

10.1093/humrep/der076 · 2011 · External reference

Time as an outcome measure in fertility-related clinical studies: long-awaited

10.1093/humrep/deaa138 · 2020 · External reference

The updated understanding of advanced maternal age

10.1016/j.fmre.2023.09.013 · 2024 · External reference

The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening

10.1016/j.fertnstert.2013.11.004 · 2014 · External reference

Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity

10.1016/j.fertnstert.2020.10.051 · 2021 · External reference

Reproduction at an advanced maternal age and maternal health

10.1016/j.fertnstert.2015.03.004 · 2015 · External reference

Delayed child-bearing

10.1016/s1701-2163(16)35138-6 · 2012 · External reference

Unresolved reference

External reference

ART in Europe 2019: results generated from European registries by ESHRE†

10.1093/humrep/dead197 · 2023 · External reference

Female ageing and reproductive outcome in assisted reproduction cycles

10.11622/smedj.2014081 · 2014 · External reference

Projecting the contribution of assisted reproductive technology to completed cohort fertility

10.1007/s11113-023-09765-3 · 2023 · External reference

Childbirth timing and completed family size by the mode of conception-the role of medically assisted reproduction: a population-based cohort study in Australia

10.1016/j.lanwpc.2023.100686 · 2023 · External reference

Evolution of cumulative live birth and dropout rates over six complete IVF/ICSI cycles: a large prospective cohort study

10.1016/j.rbmo.2021.01.005 · 2021 · External reference

What do healthy women know about the consequences of delayed childbearing

10.1080/10810730.2013.825677 · 2013 · External reference

Age and fertility: a study on patient awareness

10.5935/1518-0557.20160024 · 2016 · External reference

Awareness, knowledge, and perceptions of infertility, fertility assessment, and assisted reproductive technologies in the era of oocyte freezing among female and male university students

10.1007/s10815-016-0717-1 · 2016 · External reference

Knowledge of age-related fertility decline in women: a systematic review

10.1016/j.ejogrb.2018.09.030 · 2018 · External reference

Guidelines informing counseling on female age-related fertility decline: a systematic review

10.1007/s10815-020-01967-4 · 2021 · External reference

ESHRE guideline: female fertility preservation†

10.1093/hropen/hoaa052 · 2020 · External reference

Assisted reproduction with advancing paternal and maternal age: an Ethics Committee opinion

10.1016/j.fertnstert.2025.03.031 · 2025 · External reference

Achieving two live births from one ovarian stimulation cycle: the one-and-done approach revisited

10.1016/j.fertnstert.2025.07.029 · 2026 · External reference

Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis

10.1016/j.rbmo.2019.06.013 · 2019 · External reference

Is more better? A higher oocyte yield is independently associated with more day-3 euploid embryos after ICSI

10.1093/humrep/dey342 · 2019 · External reference

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles

10.1093/humrep/der106 · 2011 · External reference

Cumulative live birth rates for women returning to ART treatment for a second ART-conceived child

10.1093/humrep/deaa030 · 2020 · External reference

A novel predictive model to estimate the number of mature oocytes required for obtaining at least one euploid blastocyst for transfer in couples undergoing in vitro fertilization/intracytoplasmic sperm injection: the ART Calculator

10.3389/fendo.2019.00099 · 2019 · External reference

Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection

10.3389/fendo.2019.00917 · 2019 · External reference

The number of autologous, vitrified mature oocytes needed to obtain three euploid blastocysts increases with age

10.1016/j.fertnstert.2025.04.023 · 2025 · External reference

Unresolved reference

External reference

Fertility and the aging male

2011 · External reference

The spectrum of DNA damage in human sperm assessed by single cell gel electrophoresis (Comet assay) and its relationship to fertilization and embryo development

10.1093/humrep/17.4.990 · 2002 · External reference

Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles

10.1016/j.fertnstert.2007.06.009 · 2008 · External reference

The effect of paternal age on outcome in assisted reproductive technology using the ovum donation model

10.1177/1933719113506497 · 2014 · External reference

High aneuploidy rates observed in embryos derived from donated oocytes are related to male aging and high percentages of sperm DNA fragmentation

10.4137/cmrh.s32769 · 2015 · External reference

Unresolved reference

2021 · External reference

APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function

10.1016/j.rbmo.2023.103647 · 2024 · External reference

Normozoospermic men in infertile couples: Potential benefit of early medical diagnostic procedures

10.1111/andr.70035 · 2025 · External reference

Shifting the reproductive window: The contribution of ART and egg donation to fertility rates in the UK

10.1080/00324728.2025.2561595 · 2025 · External reference

ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction-a guide for fertility staff

10.1093/humrep/dev177 · 2015 · External reference

Number of oocytes and IVF outcomes: real-world evidence

10.1016/j.bpobgyn.2023.102341 · 2023 · External reference

Can you ever collect too many oocytes

10.1093/humrep/deu272 · 2014 · External reference

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles

10.1016/j.fertnstert.2013.12.026 · 2014 · External reference

Optimal oocyte yield for cumulative live-birth rate: analysis of 257,398 IVF cycles and their linked fresh and frozen embryo transfers

10.1016/j.fertnstert.2016.07.559 · 2016 · External reference

Cumulative live birth and surplus embryo incidence after frozen-thaw cycles in PCOS: how many oocytes do we need

10.1007/s10815-017-0959-6 · 2017 · External reference

Optimal number of oocytes: in vitro fertilization predictive model

2017 · External reference

The number of oocytes retrieved during IVF: a balance between efficacy and safety

10.1093/humrep/dex334 · 2018 · External reference

Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women

10.1016/j.fertnstert.2018.04.039 · 2018 · External reference

Is there an optimal number of oocytes retrieved at which live birth rates or cumulative live birth rates per aspiration are maximized after ART? A systematic review

10.1016/j.rbmo.2020.10.008 · 2021 · External reference

Female age is associated with the optimal number of oocytes to maximize fresh live birth rates: an analysis of 256,643 fresh ART cycles

10.1016/j.rbmo.2020.11.010 · 2021 · External reference

The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China

10.1093/humrep/det303 · 2013 · External reference

Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos

10.1093/humrep/dev316 · 2016 · External reference

Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old

10.1093/humrep/dey295 · 2018 · External reference

The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles

10.1093/humrep/dez100 · 2019 · External reference

DuoStim - a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review

10.1080/03009734.2020.1734694 · 2020 · External reference

Safety and effectiveness of ten common in-vitro fertilisation add-ons: a systematic review and meta-analysis

10.1016/s3050-5038(26)00054-3 · 2026 · External reference

PGT-A is associated with a reduced live birth rate in routine practice: evidence from the UK ART register

10.1016/j.rbmo.2026.105747 · 2026 · External reference

PGDIS position statement on the transfer of mosaic embryos 2021

10.1016/j.rbmo.2022.03.013 · 2022 · External reference

Clinical management of mosaic results from preimplantation genetic testing for aneuploidy of blastocysts: a committee opinion

10.1016/j.fertnstert.2023.08.969 · 2023 · External reference

Good practice recommendations on add-ons in reproductive medicine†

10.1093/humrep/dead184 · 2023 · External reference

The use of preimplantation genetic testing for aneuploidy: a committee opinion

10.1016/j.fertnstert.2024.04.013 · 2024 · External reference

Unresolved reference

External reference

The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool

10.1007/s10815-018-1275-5 · 2018 · External reference

PGT-A: what's it for, what's wrong

10.1007/s10815-025-03400-0 · 2025 · External reference

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial

10.1093/humrep/del284 · 2006 · External reference

Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study

10.1093/humrep/den220 · 2008 · External reference

Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients

10.1016/j.fertnstert.2007.05.039 · 2008 · External reference

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer

10.1016/j.fertnstert.2011.12.016 · 2012 · External reference

Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial

10.3109/09513590.2011.650742 · 2012 · External reference

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection

10.1016/j.fertnstert.2020.03.029 · 2020 · External reference

Recombinant follicle-stimulating hormone (rFSH) versus other recombinant or urinary gonadotropins for ovarian stimulation in assisted reproductive technology cycles

10.1002/14651858.cd005354.pub3 · 2026 · External reference

Follicle-stimulating hormone biological products: does potency predict clinical efficacy

10.3390/ijms24109020 · 2023 · External reference

Follitropin alfa biosimilars: unfounded doubts on the road to reproductive care

10.1093/humrep/deaf143 · 2025 · External reference

Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis

10.1093/humrep/deae274 · 2025 · External reference

Methodological concerns and clinical relevance: a critical appraisal of the meta-analysis on biosimilars versus originator follitropin alfa in ART

10.1093/humrep/deaf144 · 2025 · External reference

Reply: biosimilars versus the originator of follitropin alfa in ART: eyes wide shut

10.1093/humrep/deaf145 · 2025 · External reference

Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35-40 years

10.1016/j.rbmo.2023.103725 · 2024 · External reference

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials

10.1186/s12958-021-00759-4 · 2021 · External reference

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

10.1093/humrep/der092 · 2011 · External reference

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)

10.1002/14651858.cd012693.pub2 · 2018 · External reference

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)

10.1002/14651858.cd012693.pub3 · 2024 · External reference

Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis

10.1093/humupd/dmae032 · 2025 · External reference

Biomarkers of ovarian response: current and future applications

10.1016/j.fertnstert.2012.11.051 · 2013 · External reference

How to personalize ovarian stimulation in clinical practice

10.4274/jtgga.2017.0058 · 2017 · External reference

Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (FOI) index

10.3389/fendo.2018.00589 · 2018 · External reference

Decision points for individualized hormonal stimulation with recombinant gonadotropins for treatment of women with infertility

10.1080/09513590.2019.1650345 · 2019 · External reference

Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years, (2007-2017)

10.1186/s12958-021-00744-x · 2021 · External reference

Recombinant human follicle-stimulating hormone alfa dose adjustment in US clinical practice: an observational, retrospective analysis of a real-world electronic medical records database

10.3389/fendo.2021.742089 · 2021 · External reference

Too many embryos: a critical perspective on a global challenge

10.1007/s10815-024-03159-w · 2024 · External reference

Aging conundrum: a perspective for ovarian aging

10.3389/fendo.2022.952471 · 2022 · External reference

Age-associated changes in cumulus cells and follicular fluid: the local oocyte microenvironment as a determinant of gamete quality

10.1093/biolre/ioab241 · 2022 · External reference